‘Lived in fear of heart attack’: Abu Dhabi woman successfully treated for spasms undetected for long
The 61-year-old's symptoms were concerning, especially considering her highly active lifestyle, said doctors
British drugmaker AstraZeneca Plc told Reuters on Tuesday its Covid-19 vaccine should be effective against the new coronavirus variant, adding that studies were under way to fully probe the impact of the mutation.
"AZD1222 (AstraZeneca's vaccine candidate) contains the genetic material of the SARS-CoV-2 virus spike protein, and the changes to the genetic code seen in this new viral strain do not appear to change the structure of the spike protein," an AstraZeneca representative said in an email.
Also read: BioNTech-Pfizer vaccine heads to EU as effectiveness against new Covid strain tested
New Covid strain: Vaccine developer says it can make new jab in 6 weeks
Drugmakers are scrambling to test their Covid-19 vaccines against the new fast-spreading variant of the virus that is raging in Britain, the latest challenge in the breakneck race to curb the pandemic.
"Through vaccination with AZD1222, the body's immune system is trained to recognise many different parts of the spike protein, so that it can eliminate the virus if it is later exposed," the AstraZeneca representative added.
The mutation known as the B.1.1.7 lineage may be up to 70 per cent more infectious and more of a concern for children. It has sown chaos in Britain, prompting a wave of travel bans that are disrupting trade with Europe and threatening to further isolate the island country.
The AstraZeneca-Oxford shot is considered vital for lower-income countries and those in hot climates because it is cheaper, easier to transport and can be stored for long periods at normal refrigerator temperatures.
Data from AstraZeneca's late-stage trials in the UK and Brazil released earlier this month showed the vaccine had efficacy of 62 per cent for trial participants given two full doses, but 90% for a smaller sub-group given a half, then a full dose.
Reuters reported late on Tuesday that India is likely to approve AstraZeneca's vaccine for emergency use by next week.
The 61-year-old's symptoms were concerning, especially considering her highly active lifestyle, said doctors
Holiday homes are increasingly gaining traction, witnessing huge growth in occupancy rates as the demand surges
In 2023, a trial was conducted to study the sleeping and feeding patterns of the animals
The beachfront resort in Ras Al Khaimah's Al Marjan is being built on an island of almost 62 hectares
With a proficient staff and cutting-edge technology, the hospital ensures accurate and timely test results, minimising any delays in the application process
Dubai's rental market thrives as the city attracts a growing population of residents, while Metahomes greets home hunters with a user-friendly experience and a vast selection of listings
Business expert presents cutting-edge solutions to clients in emerging and newly developed markets
PhysioTherabia has partnered with the leading insurance provider Takaful Al Arabia, in addition to Tawuniya, and has started engaging with other health insurance companies to ensure business scalability